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ABSTRACT
Dupuytren's disease is a benign contractile disorder of the hand. The condition commonly affects older men of Celtic descent. Although fi broproliferation and collagen alteration play a role in its etiology, defi ning a cause remains elusive. Nonoperative intervention for advanced disease has shown only short-term benefi t. Therefore, open fasciectomy has become the mainstay of treatment. Associated morbidity and recurrence have prompted investigation into less invasive techniques, including needle aponeurotomy and enzymatic fasciotomy. Data from phase III studies using injectable collagenase are changing treatment algorithms. Postoperative rehabilitation includes nighttime splinting and immediate active range of motion exercises to facilitate return to function.
As a result of reading this article, physicians should be able to:
1. Identify the basic science associated with the pathogenesis of Dupuytren's disease as it is defi ned to date.
Defi ne the anatomy, pathologic and nonpathologic, involved with
Dupuytren's disease.
3.
Identify the clinical presentation of patients with Dupuytren's disease.
4.
Discuss traditional and cutting-edge operative and nonoperative treatment options, including postoperative care. 1 In 1777, English surgeon Henry Cline suggested a role for the palmar fascia in this contractile disorder and, in 1808, specifi ed involvement of the palmar aponeurosis. 2 Cline further proposed operative release of the contracted aponeurosis as a treatment option while stressing the importance of understanding the proximity of abnormally positioned neurovascular structures during dissection.
Sir Astley Cooper, a student and apprentice of Cline, theorized that a chronic infl ammatory condition of the palmar aponeurosis could lead to contrature of the involved digits, a theory proposed years before Dupuytren's work on the disorder was formally published. Cooper proposed repetitive trauma as an etiologic factor for the onset of the contracture and agreed with his mentor's suggestion that operative release of diseased tissue could be benefi cial. 2 In 1831, Guillaume Dupuytren, a French anatomist and military surgeon, presented his detailed anatomic and pathologic description of what is now known as Dupuytren's disease. Given his stature in the medical community, the contracture came to bear his name.
BASIC SCIENCE
A large infl ux of information over the past 3 to 4 decades regarding the basic science of Dupuytren's disease has improved our understanding of the primary role fi broblasts and myofi broblasts play in disease development and progression. Myofi broblasts are the primary cell type found in diseased tissue. These cells have been shown to be biochemically similar, if not identical, to myofi broblasts found in normal tissue. 3 This information brings into question the former theory that an altered form of myofi broblast is responsible for Dupuytren's disease.
Studies of collagen type and deposition in diseased tissue have shown higher concentrations of type III collagen resulting in a higher ratio of type III collagen to type I collagen. 3 These data have confi rmed the role alterations in collagen development and deposition play in Dupuytren's disease.
Cellular ischemia results in cytokinemediated transformation of fi broblasts to myofi broblasts in diseased tissue. This mechanism of transformation is thought to be a cause of increased myofi broblast proliferation leading to eventual contracture. In this algorithm, an episode of local ischemia stimulates fi broblast proliferation in a mechanism still incompletely understood but thought to be related to the production of free radicals. 4 While a cause-and-effect relationship has yet to be proven with Dupuytren's disease, the higher prevalence of the disorder seen in patients with characteristics such as alcohol consumption, cigarette smoking, and human immunodefi ciency virus (HIV) is well established. 4, 5 This association may be due to free radical development in such patient populations. With an increase in free radical formation, a cycle of myofi broblast proliferation leading to local ischemic events is created, further contributing to disease progression. 3 More recent literature has studied the roles genetic predisposition, enzymatic pathways, and biochemical profi les play in Dupuytren's disease development, progression, prognosis, and treatment. DNA microarrays have been used to evaluate the expression of genes in diseased tissue. In one such study on abnormal collagen expression in Dupuytren's disease, an upregulation of collagen synthesis gene expression combined with simultaneous down regulation of collagenase gene expression explained the alteration of collagen types seen in Dupuytren's disease. 6 Specifi c biomarkers have been identifi ed in Dupuytren's tissue and are now being used to provide laboratory values for prognosis and treatment. While not necessarily unique to Dupuytren's disease, a disintegrin and metalloproteinase domain 12 (ADAM12), periostin (POSTN), and tenascin C (TNC) are all abnormally expressed in diseased tissue. 7 In addition, ADAM12 and TNC are associated with the transforming growth factor beta (TGF-␤) pathway, 7 a pathway known to have direct and indirect effects on fi broblast/myofi broblast contraction and proliferation. 8 Myofi broblast contractility is also associated with and enhanced by sphingoseine-1-phosphate (S1P) activation of non-muscle myosin II (NMMII). 9 Identifi cation of the S1P pathway is being studied as a possible target for nonoperative treatment of Dupuytren's disease.
Finally, chromosomes 6, 11, and 16 have been identifi ed as being the loci for many, if not all, of the genes associated with Dupuytren's, thus providing a genetic basis for evaluation and treatment.
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ANATOMY
An understanding of normal palmar fascial anatomy is necessary for proper evaluation and treatment of Dupuytren's disease. The changes seen in diseased tissue are a result of progressive pathologic changes in normal anatomy. Nomenclature used for normal structures includes bands and ligaments, whereas diseased tissues are referred to as nodules and cords ( Figure 1) .
The palmar fascial complex as described by Rayan 11 is composed of 5 fascial structures: the radial, ulnar, and central aponeuroses and the palmodigital and digital fascia. All are involved in Dupuytren's disease to a varying degree. Of these, the triangular-shaped fascial layer known as the central or palmar aponeurosis 11, 12 is thought to be the center of Dupuytren's disease activity. Classically, with disease progression, the more distally located palmodigital and digital fascia become increasingly involved, resulting in the metacarpophalangeal (MCP) joint and proximal interphalangeal (PIP) joint contraction seen clinically.
The palmar aponeurosis is composed of fi bers oriented in longitudinal, trans-cme ARTICLE verse, and vertical planes. Distal continuation of the longitudinal fi bers culminates in discretely organized structures known as pretendinous bands. These pretendinous bands fan out and bifurcate to the 3 central digits in the distal palm. Each pretendinous band is composed of 3 distinct layers. 13 The most superfi cial layer of each band inserts directly into the dermis just distal to the distal palmar crease. 12 The middle layer continues to the digit as the spiral band, rotating 90Њ around both sides of the metacarpal head, partially attaching to the MCP joint capsule and overlying soft tissues. 12 The deep layer extends in a vertical/dorsal direction. 13 Just proximal to the palmodigital junction, transversely oriented fi bers contribute to the natatory ligament at each web space, the transverse ligament of the palmar aponeurosis, the proximal commissural ligament, and the septa of Legueu and Juvara. Located perpendicular and deep to the pretendinous bands and just proximal to the natatory ligament in the distal palm is the transverse palmar ligament. 12, 13 The natatory ligament runs between web spaces in the distal palm and has attachments to the soft tissues around the MCP joints, fl exor tendon sheaths, and skin in each web space. 12 Vertical fi bers, in conjunction with slips from the transverse fi bers, constitute the septa of Legueu and Juvara. Seven compartments are formed by these septa that surround fl exor the tendons, lumbricals, as well as the common digital nerves and arteries in the hand (Figure 2) . 11, 14, 15 The palmodigital junction defi nes the transition from the central aponeurosis of the palm to the fascia of each digit at the level of the web space. It is at this junction that the middle layer of the pretendinous band spirals around the MCP joint to become the spiral band. As the band spirals, it travels deep to the neurovascular bundle and natatory ligaments before emerging distally and combining with distal fi bers of the natatory ligament to form the lateral digital sheet. The lateral digital sheet continues distally, sending fi bers oriented either volar or dorsal to the neurovascular bundle along its course. The fi bers attach to the tendon sheath, periosteum, and joint capsule with connections to the subcutaneous tissue and skin. Those fi bers oriented volar to the neurovascular bundle are called Grayson's ligaments and those passing dorsal are Cleland's ligaments.
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PATHOANATOMY
Pathologic tissues in Dupuytren's disease are grouped broadly into being either nodules or cords. Controversy exists as to which structure develops fi rst or whether they develop simultaneously.
Early descriptions of the myofi broblast and its role in Dupuytren's disease were made by Gabbiani et al 17 and Tomasek et al. 18 Newer data confi rming the role of myofi broblasts in cord contraction have studied myofi broblast distribution within nodules and cords. Nodules were found to have an increased density of myofi broblasts that contributed to the contraction of diseased cords. In contrast, cords were found to be relatively hypocellular structures.
Contraction of myofi broblasts in diseased nodules results in deposition of an extracellular matrix that, through a process of remodeling, leads to shortening of the cord. In addition, myofi broblastic apoptosis during this process leads to relative hypocellularity of the cord and worsening of the fl exion deformity. 19 Cords can shorten in a progressive manner, leading to joint and soft tissue contracture. Also, cords develop from or along the same 3-dimensional pathways as normal tissue and are fairly predictable in their location and effect on surrounding soft tissues, joints, and neurovascular structures. Proper management acknowledges the fact that the orientation of diseased tissue is found not to be isolated to a longitudinal plane but involves a 3-dimensional space from the palm to the digit.
A thorough understanding of normal fascial anatomy of the palm and involvement of the neurovascular bundle is necessary for safe and effective operative treatment of Dupuytren's disease. Terminology used when defi ning diseased vs normal tissue defi nes bands, sheaths, and ligaments as normal anatomy, whereas nodules and cords are reserved for diseased tissues (Table) .
The pretendinous cord develops from the pretendinous band and palmar fi brofatty fascia. It is responsible for much of the MCP joint fl exion seen in Dupuytren's disease and is the most common cord seen clinically. However, it can also contribute 2 cme ARTICLE to concomitant MCP and PIP joint contracture as it progresses distally as a central cord. Its insertion distally includes the skin overlying the proximal phalanx, the tendon sheath distal to the PIP joint, the periosteum at the middle phalangeal base, and the lateral digital sheet. Although intimately associated with the neurovascular bundle along its course, it does not cause bundle displacement as often as other cords. Occasional bifurcation of the pretendinous cord to separate digits can be seen as a commissural cord.
The spiral cord is a compilation of 4 fascial structures including the pretendinous band, spiral band, lateral digital sheet, and Grayson's ligament (Figure 3) . 20, 21 These structures coalesce in the digit and contract, causing predictable displacement of the neurovascular bundle proximal, central, and superfi cial to its in situ location. 20, 22, 23 Early in the disease process, the cord will spiral around the neurovascular bundle following lines of normal fascial anatomy. However, with disease progression, the cord becomes taut and straight, causing the neurovascular bundle to spiral around the cord. The spiral cord can cause increasingly severe PIP joint contracture to the point that the likelihood of a spiral cord being present is increased if PIP contracture is seen clinically.
The natatory cord arises from the natatory ligament and is the only structure at the palmodigital junction not to be directly involved with the spiral cord. Progression of the natatory cord leads to contracture of the second through fourth web spaces. Passive abduction of the involved digits with subsequent fl exion of 1 and extension of the other at the MCP joint causes the cord to become more prominent. 24 The central cord is a distal extension of the pretendinous cord found in the palm and can cause contraction of the PIP joint. Involvement and contracture of the lateral digital sheet in the digit is termed a lateral cord. Its insertion to the skin or fl exor tendon near Grayson's ligament leads to contracture of the PIP joint. In addition, contracture of the distal interphalangeal (DIP) joint should raise awareness for the possibility of this cord being present. It may cause displacement of the neurovascular bundle depending on its mass within the digit. Of note, the ulnar aspect of the small fi nger does not contain a lateral digital sheet as a discreet structure. However, the tendon of the abductor digiti minimi muscle can serve as a nidus for an abductor digiti minimi cord found in 25% of patients with a small fi nger contracture. 20 This cord can displace the neurovascular bundle midline. Care must be taken when approaching the small fi nger to avoid damage to the dorsal ulnar sensory nerve that can be displaced from its normal anatomic position into one more susceptible to injury during dissection. 20 A retrovascular cord involves tissue just dorsal to the neurovascular bundle, excluding Cleland's ligament, which is normally spared in Dupuytren's disease. This cord alone does not directly cause contracture of the PIP joint, but may be a cause of residual PIP contracture if not completely removed due to its effect on the surrounding soft tissues. In addition, it is the most common cause of DIP joint contracture.
Commissural cords are products of natatory and transverse ligament extensions near the fi rst web space. If the thumb is involved, contraction of these cords can lead to diffi culty with pinch and grasp and may require excision if severe disability is present.
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CLINICAL FEATURES
Dupuytren's disease is a disorder of autosomal dominant inheritance with Dupuytren's disease is more common as one ages, with patients older 40 years being at increased risk. 25 It is also more common in men than women, at a ratio of 9 to 1. 26 While a cause-and-effect relationship has yet to be proven, diabetes mellitus, alcohol use, smoking, and HIV have all been associated with a higher risk of Dupuytren's disease development. 5, 20 Presentation for clinical evaluation is many times delayed secondary to the relatively painless nature of Dupuytren's disease progression. Patients are often referred by their primary care physician for evaluation of a trigger fi nger, tendon adhesions, or joint arthritis due to decreased fi nger range of motion (ROM) or contraction. Classically, the fi rst clinical signs reported by the patient are skin pitting and thickening or nodule formation near the MCP joint on the palm of the hand. Patients may also present with more advanced disease secondary to diffi culty with placement of the hand in a pocket or inability to fl atten their fi ngers on a table.
Following skin pitting and thickening, early disease progression presents as nodule and cord formation in the palm. The ring and small fi ngers are affected fi rst, and most often in that order. Following the ring and small fi ngers, the long fi nger, index fi nger, and thumb may also be affected, in that order. 22, 27 In women and patients with diabetes mellitus, initial presentation and progression may differ from that found in men. Isolated PIP or web space involvement in women and radial digit involvement in patients with diabetes mellitus may be misdiagnosed as something other than Dupuytren's disease early in the process. 20 As cord development progresses, signifi cant fi ndings in the palm and digits can become clinically impressive and disabling. A failed tabletop test, as described by Hueston, 28 in which the patient cannot lay his or her palm and fi ngers simultaneously fl at on a hard surface, helps in the screening process for Dupuytren's disease. A positive test has been shown to correlate with alterations in hand function and MCP joint contracture of approximately 40Њ. 28 In patients younger than 40 to 50 years at onset with early, aggressive cord formation and multiple physical fi ndings including knuckle pads (aka Garrod's nodes), plantar fi bromatosis (Lederhose's disease), and penile involvement (Peyronie's disease), a diagnosis of Dupuytren's diathesis should be considered. These patients are at higher risk for recurrence, poor operative outcomes, signifi cant complications, and less satisfying rehabilitation. While operative treatment is not contraindicated in this population, such risks should be thoroughly discussed prior to treatment.
The risk of recurrence after treatment is controversial due in part to the lack of standardized defi nitions of recurrent disease. Documented from 8% to 54%, the risk of recurrence and diffi culty in predicting outcomes should be discussed with every patient prior to operative and nonoperative intervention. 20 While the risk of disease recurrence seems high at fi rst, the risk of recurrence requiring further intervention is much lower. 20 Whether recurrence is due to incomplete excision, new disease formation, or disease persistence and progression is also debatable. Younger patients and those with strong genetic tendencies (ie, diathesis) are at higher risk of recurrence. Finally, while the operative technique used has not been associated with higher recurrence risk, 20 the use of full-thickness skin grafting to areas of excision has been postulated to decrease the rate of recurrence. 4 
MANAGEMENT
Operative intervention continues to be the gold standard for treatment of Dupuytren's disease and is indicated in cases of advanced disease, contractures interfering with activities of daily living, and in cases where patient preference dictates operative intervention. Specifi cally, a positive tabletop test is correlated with MCP joint contractures of 30Њ to 40Њ and refl ects the stage at which inability to use the hand in a normal fashion is present. 20 Proximal interphalangeal joint contracture of у20Њ has traditionally been an indication for operative or invasive intervention. However, due to the diffi culty of correcting severe PIP joint deformity, caution should be observed when suggesting operative intervention simply due to PIP joint contracture.
Numerous nonoperative modalities, including splinting, physical therapy, and corticosteroid injections, have not been found to be benefi cial with regard to longterm outcomes. In addition, recent interest in medicinal treatment of Dupuytren's disease, 29 the role of matrix metalloproteinase in fi broblast contracture, 30 and the use of the combination of an angiotensin convering enzyme (ACE) inhibitor/Nacetyl-L-cystein in TGF-␤1 inhibition for Dupuytren's disease prevention 31 have added to an already long list of nonoperative treatment options for Dupuytren's patients. However, due to the variable course of early Dupuytren's disease progression, those patients with less severe clinical fi ndings or symptoms should be encouraged to continue to use the affected hand in a normal fashion, as observation is the mainstay of treatment for early disease.
Options for operative intervention are numerous and include radical, regional, or limited fasciectomy, dermatofasciectomy, segmental fasceictomy, percutaneous needle fasciotomy, and fasciotomy using local collagenase injection.
Once the mainstay of treatment for Dupuytren's disease, McIndie and Beare's radical fasciectomy 32 has fallen out of fa-vor due to persistence of recurrence, the invasive nature of the procedure, and adequate outcomes using a less invasive approach. More often, a selective or regional palmar fasciectomy is performed. The procedure requires less invasive dissection than a radical approach and removes only diseased tissue in the region affected by the disease process. 33 are also well-accepted options. Initial splinting in a bulky dressing for the fi rst 3 to 7 days postoperatively, followed by active and passive ROM exercises, is advocated. Nighttime splinting for up to 4 months is often necessary to maintain an extended posture of the affected digits during the rehabilitation period.
A recent review article discussing complications following open fasciectomy over 20 years reported an overall complication rate of 3.6% to 30.1%. 34 On average, wound-healing complications were the most prevalent at a rate of 22.9%, followed by digital nerve injury (3.4%), infection (2.4%), and digital artery injury (2.0%). A higher rate of complications associated with revision surgery for recurrent disease was also reported. 34 Recurrence rates for open treatment of Dupuytren's disease vary signifi cantly due to the lack of standardized guidelines defi ning recurrence and the variable nature of follow-up. It must be noted that recurrence rates requiring revision or repeat operative intervention are lower than recurrence rates alone. 20 A recurrence range of 0% to 71% was reported in an outcomes review of operative treatment for primary Dupuytren's disease. 35 Full-thickness or "fi rebreak" fl aps of tissue for coverage after open fasciectomy have been studied as a means to decrease recurrence rates. 36 In a comparison between the open technique of McCash and a full-thickness skin graft, Skoff et al 37 reported a 50% recurrence rate with the open palm technique vs 0% recurrence with the full-thickness graft. After 3 years, outcomes comparing dermofasciectomy with full-thickness skin graft and z-plasty over the PIP joint were reported in a prospective randomized study. No statistical signifi cance between the 2 and a combined recurrence of 12.2% was reported. 36 Finally, concomitant fasciectomy and carpal tunnel realease has traditionally been avoided due to an unacceptably high rate of complex regional pain syndrome (CRPS). 38, 39 More recent data, however, retrospectively indicated that the rate of CRPS may be much lower than originally thought and that simultaneous undertaking of 2 procedures may be advantageous. 40 Incisions for open procedures range from midaxial longitudinal incisions extending into the digit from the palm and Brunner zigzag incisions to V-Y advancement fl ap closure. A longitudinal incision in theory may put the centrally displaced neurovascular bundle at higher risk of damage. However, careful dissection coupled with thorough knowledge of the diseased anatomy makes this approach relatively safe. Closure of the incision is preformed using a z-plasty technique to provide more pliable tissue for closure in addition to allowing for lengthening of the incision.
The relative simplicity of planning, excellent exposure, and the option to leave a portion of the incision open to be closed with skin grafting if necessary has popularized the Brunner zigzag incision for the majority of operative cases.
With exposure, great care must be taken to create full-thickness fl aps that respect not only the diseased tissue and endangered neurovascular bundle but also the necessity of closure and wound healing. Avoidance of skin and wound-edge necrosis through atraumatic technique, suturing of the fl ap edge to adjacent skin to avoid vigorous retraction, and closure void of any undue tension are requisite for a successful outcome.
Originally described by Russ in 1908, segmental fasciectomy involves multiple small incisions along the course of the diseased cord. Through these incisions, segments of diseased tissue are removed, thus disrupting the structure of the cord. Recurrence rates as low as 21% have been reported using this technique, 41, 42 but open operative fasciectomy remains the standard of care.
Less invasive procedures, such as percutanous needle fasciotomy (PNF) and injectable collagenase, have been developed in an attempt to match outcomes similar to those seen with operative treatment but avoid the morbidity associated with open procedures.
Percutaneous needle fasciotomy has gained popularity as being the least invasive of operative treatment options, making it a favorable choice for those patients not amenable to more invasive procedures. Performed under local anesthesia, PNF involves injection of anesthetic in an intradermal manner surrounding the cords to be released. Using the technique similar to that originally described by Sir Astley Cooper and modifi ed by Eaton, 43 a 25-gauge needle is used as a scalpel, sweeping in a path transverse to the cord from superfi cial to deep, causing transection of the cord. Constant tension on the cord during the procedure aids in avoiding injury to underlying neurovascular bundle and fl exor tendon. 43 Short-term results using PNF have been favorable, with contractures of the MCP joints showing the most improvement. 44 [46] [47] [48] Proponents of the injection cite the less invasive nature of the procedure, avoidance of extensive hand therapy after treatment, lack of signifi cant adverse events, and promising short-term (8-year) outcomes as being strengths for the injection, especially with regard to treatment of MCP joint contracture. [48] [49] [50] However, criticism of the clostridium injection relates a higher rate of minor adverse events, patient-reported apprehension for the procedure, lack of long-term outcome studies, and a current cost of $5400 per injection as being the downside to the procedure. 49, 51 Proximal interphalangeal joint involvement introduces an additional confounding factor in the treatment of Dupuytren's disease. Controversy exists with regard to the degree at which PIP joint contracture should be corrected. Methods of correction include simple excision of diseased Dupuytren's tissue, excision with extensive capsular release, and release of soft tissues surrounding the PIP joint. McFarlane et al reported poorer outcomes with operative intervention for PIP joint contractures of Ͻ30Њ and suggested release only when PIP joint contracture exceeded 30Њ. In addition, a dynamic PIP joint contracture must be considered when associated MCP fl exion contracture is seen in the same digit. Due to the pathoanatomy of advanced cords in the digits, a well-developed spiral cord may cause contracture of both the MCP and PIP joints, and release of the MCP contracture may resolve deformity seen at the PIP joint. Postoperative maintenance of PIP correction is unpredictable and involves long-term extension splinting. Rives et al reported only 44% improvement in PIP joint extension for contractures of у45Њ undergoing additional PIP soft tissue release during Dupuytren's fasciectomy. 52 Strict adherence to the postoperative splinting protocol was predictive of outcome in their study. A compliant patient population is therefore necessary for successful treatment. Based on the idea that MCP joint compensation can overcome signifi cant PIP joint contracture, Hueston suggested intervention for PIP contracture only if Ͼ40Њ. 53 Due to the complexity in treating PIP joint contracture, a discussion must be had with the patient regarding the possibility that any PIP joint correction attained intraoperatively may not be longstanding. Also, by attempting to correct severe contracture at the PIP joint, the risk of complication during the procedure is elevated, especially if signifi cant soft tissue dissection is necessary.
POSTOPERATIVE CARE
Postoperative treatment algorithms have been developed specifi c to the intervention preformed, but all encourage early fi nger ROM. For open operative treatment, postoperative care consists of a bulky soft dressing that is maintained for 3 to 5 days. Elevation of the affected extremity until swelling subsides is also encouraged. After this time, a forearm-based splint is fabricated specifi c to the patient's anatomy, placing the fi ngers and thumb in an extended position to minimize postoperative contracture. Aside from therapy, the splint is worn full time for the fi rst 2 weeks postoperatively. Active ROM exercises are initiated with supervised therapy during the fi rst postoperative week, encouraging active motion in both fl exion and extension. Full-time extension splinting is progressively weaned through the second postoperative week. Nighttime splinting is continued for a total of 3 to 6 months. Strengthening exercises begin at 3 to 4 weeks for wounds closed primarily that have completely healed. Such exercises are delayed until 4 to 6 weeks for wounds closed using skin grafts or the open palm technique. The goals of therapy postoperatively are to avoid stiffness and contracture, maintain ROM attained during surgery, regain strength similar to that of preoperative levels, and decrease scarring and edema in the affected digits.
Postoperative care following clostridium injection is similar to that of an open technique, but allows for earlier return to use of the affected hand due to the less invasive nature of the procedure. After injection, a guided fi nger extension procedure is preformed up to 3 times per day to facilitate cord disruption. 48, 49 Following complete cord release, an extension splint is worn for up to 4 months. A home therapy program consisting of active ROM and return to normal activities as tolerated is implemented immediately, with formal therapy introduced on an individual basis. 49 
COMPLICATIONS
The possibility of numerous complications exists for operative treatment of Dupuytren's disease. Causes of such complications can be related to intraoperative or technical issues, patient anatomy and pathophysiology, and complications related to postoperative or rehabilitative care.
Altered anatomy found in Dupuytren's disease, lack of experience with diseased tissue, and degree of contracture severity all play a role with regard to possible damage to neurovascular structures during contracture correction and tissue excision. The rate of digital nerve damage in cme ARTICLE patients with primary disease undergoing fasciectomy has been quoted at an average of 3.4%. 34 It is suggested that dissection in a proximal to distal direction from known to unknown beginning in the palm be the standard by which diseased fascia is excised. Meticulous care to identify neurologic structures in the fi eld prior to further dissection and excision is paramount in avoiding nerve damage. If a nerve is acutely transected, primary repair should be performed.
Vascular insult can be related to intraoperative laceration or crush injury, arterial spasm, and/or intimal hemorrhage. Acute digital artery injury has been quoted at an average of 2.0% for primary disease. 34 Acute transection requires immediate primary repair. Spasm and/or intimal hemorrhage are evaluated by fi rst manipulating the joint in question, followed by irrigation with warm saline to encourage return of fl ow. Evaluation of digits and fl aps in the proximity of a damaged vessel should be performed prior to dressing application.
Hematoma formation postoperatively can be a source of pain, delayed postoperative therapy due to stiffness, and a nidus for infection and skin necrosis. Care should be taken to evaluate the operative fi eld for any bleeding vessels and provide hemostasis with the tourniquet defl ated prior to wound closure.
Numerous fl aps are often created during excision of diseased tissue. These fl aps are often thin and subject to healing complications. Care to design fl aps with adequate blood supply is required to avoid necrosis. The management of skin pitting and severe fl exion contractures also poses a risk for skin breakdown or loss of adequate tissue for coverage. Small defects can be left open to heal by secondary intention. Full-thickness skin grafting should be used to cover areas of signifi cant loss such as is often found over long-standing MCP and PIP joint contractures.
Refl ex sympathetic dystrophy, or CRPS, deserves special attention. Defi ned by hyperemia, dysthesias, swelling, and pain out of proportion to what would be expected in a normal postoperative course, its risk is increased in women and patients undergoing simultaneous fasciectomy and carpal tunnel release. 38, 39 Careful dissection with specifi c attention paid to avoid overzealous retraction of neural structures may decrease the risk of development. If no other identifi able cause can be identifi ed for such symptoms, treatment consists of pain control modalities that may include evaluation by a pain management specialist. Selective sympathetic nerve block may also prove useful in managing this perplexing outcome.
Postoperative therapy can be delayed by the aforementioned complications and can contribute to poor objective and subjective outcomes. Ability and willingness of the patient to comply with therapy plays a substantial role in the fi nal result of operative care. Residual contracture, scar formation, stiffness, and the need for further intervention can be related not only to intraoperative technique and fi ndings but also to postoperative care. In addition, a more severe preoperative contrature, 54, 55 disease affecting the little fi nger and/or multiple fi ngers, 56 and PIP joint involvement 57 increase the risk for residual or worsening postoperative contracture.
CONCLUSION
Dupuytren's disease is a contractile disorder of the palmar fascia in the hand affecting cells of fi broblast origin. While the etiology remains unclear, it is most commonly seen in aging men of European descent and is inherited in an autosomal dominant fashion with variable penetrance. The current gold standard for treatment of severe disease is open limited fasciectomy followed by an aggressive course of therapy encouraging active ROM. Operative intervention is indicated with MCP joint contracture of at least 30Њ and/or a progressive PIP contracture of at least 20Њ to 30Њ. Due to residual postoperative contracture, controversy exists as to the minimum PIP joint contracture necessary for operative correction. The Brunner zigzag incision provides excellent exposure with adequate healing in the majority of cases. Injectable clostridium histolyticum collagenase offers a new and less invasive technique for patients with Dupuytren's disease, with immediate return to function of the affected hand. Recurrence rates remain controversial independent of the technique used, and, as such, patient expectations should be evaluated and discussed prior to operative intervention, especially in those patients with Dupuytren's diathesis.
